Acquired long QT syndrome: a preoccupying problem?;QT long acquis : un problème envahissant ?

Annales de Cardiologie et d'Angeiologie

Volumn 55, Issue 6, 2006, Pages 321-327

  Barnay, C ^a   Taieb, J ^a   Morice, R ^a   Jouve, B ^a   Rahal, Y ^a   Benchaa, T ^a   Alfares, A ^a   Lenaers, C ^a   Boulain, L ^a   Pizigo, E ^a  

^a CENTRE HOSPITALIER DU PAYS D AIX   (France)

Author keywords

Acquired long; Drugs side effects; QT interval; QT syndrome; Torsades de pointes; Treatment of long

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ASTEMIZOLE; AZELASTINE; AZIMILIDE; BUTYROPHENONE; CYTOCHROME P450; DISOPYRAMIDE; DOFETILIDE; ERYTHROMYCIN; GREPAFLOXACIN; IBUTILIDE; ISOPRENALINE; LORATADINE; MACROLIDE; MAGNESIUM; MIZOLASTINE; PHENOTHIAZINE; PIMOZIDE; PSYCHOTROPIC AGENT; QUINIDINE; SEROTONIN ANTAGONIST; SERTINDOLE; SOTALOL; TERFENADINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

BRADYCARDIA; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MANUFACTURE; DRUG MARKETING; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; GENDER BIAS; HEART ARRHYTHMIA; HEART CONTRACTION; HEART DISEASE; HEART MUSCLE POTENTIAL; HEART PACING; HEART RATE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; METABOLISM; NEUROLOGIC DISEASE; NUTRITIONAL DEFICIENCY; POTASSIUM CURRENT; PREDICTION; QT PROLONGATION; REENTRY ARRHYTHMIA; RISK FACTOR; SEDATION; SHORT SURVEY; TORSADE DES POINTES; CARDIOVERSION; DRUG COMBINATION; REVIEW;

ADRENERGIC BETA-AGONISTS; DRUG THERAPY, COMBINATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HUMANS; ISOPROTERENOL; LONG QT SYNDROME; MAGNESIUM; RISK FACTORS;

EID: 33750522217     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2006.09.004     Document Type: Short Survey

References (16)

1. Dessertenne F. La tachycardie ventriculaire à deux foyers opposés variables. Arch. Mal. Cœur Vaiss. 59 (1966) 263-272
2. Tamargo J., Caballero R., Gomez R., Valenzuela C., and Delpon E. Pharmacology of cardiac potassium channels. Cardiovasc. Res. 62 (2004) 9-33
3. Thomas D., Karle C.A., and Kiehn J. Modulation of HERG potassium channels by drug action. Ann. Med. 36 Suppl 1 (2004) 41-46
4. El-Sherif N., Caref E.B., Chinushi M., and Restivo M. Mechanism of arrhythmogenicity of the short-long sequence that precedes ventricular tachyarrhythmias in the long QT syndrome. J. Am. Coll. Cardiol. 33 (1999) 1415-1423
5. El-Sherif N., Chinushi M., Caref E.B., and Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsades de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns. Circulation 96 (1997) 4392-4399
6. Roden D. Taking the idio out of idiosyncratic - predicting torsades de pointes. Pacing Clin. Electrophysiol. 21 (1998) 1029-1034
7. Priori S.G., Napolitano C., and Schwartz P.J. Low penetrance in the long QT syndrome. Clinical impact. Circulation 99 (1999) 529-533
8. Roden D. Drug induced torsades de pointes. N. Engl. J. Med. 50 (2004) 1013-1022
9. In: Camm A.J., Malik M., and Gap Y.G. (Eds). Acquired long QT syndrome (2004), Blackwell Futura, Malden (USA)
10. http://www.qtdrugs.org.
11. De Ponti F., Poluzzi E., Montanaro N., and Ferguson J. QTc and psychotropic drugs. Lancet 356 (2000) 75-76
12. Singh B.N. Antiarrhythmic actions of Amiodarone: a profile of a paradoxical agent. Am. J. Cardiol. 78 (1996) 41-53
13. Zareba W., Moss A.J., Rosero S.Z., Hajj-Ali R., Konecki J., and Andrews M. Electrocardiographic findings in patients with diphehydramine overdose. Am. J. Cardiol. 80 (1997) 1168-1173
14. Risk of QT prolongation and torsades de pointes with psychotropic drugs. In: Camm A.J., Malik M., and Gap Y.G. (Eds). Acquired long QT syndrome (2004), Blackwell Futura, Malden (USA) 102 (Chap. 7)
15. Lupoglazoff J.M., Bedu A., and Faure C. Long QT syndrome under cisapride in neonates and infants. Arch. Pediatr. 4 (1997) 509-514
16. Coumel P. Safety of bepridil: from review of the European data. Am. J. Cardiol. 69 (1992) 75D-78D